Watkins Tim (CIK 2065965) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy CTNM (10,833 shares), Sell CTNM (10,833 shares), Buy CTNM (3,611 shares), Sell CTNM (3,611 shares), Buy CTNM (3,611 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Contineum Therapeutics, Inc. (CTNM) | CMO & Head of Development | Buy | 10,833 | $48,748 |
| 2026-07-01 | Contineum Therapeutics, Inc. (CTNM) | CMO & Head of Development | Sell | 10,833 | $173,590 |
| 2026-03-02 | Contineum Therapeutics, Inc. (CTNM) | CMO & Head of Development | Buy | 3,611 | $16,250 |
| 2026-03-02 | Contineum Therapeutics, Inc. (CTNM) | CMO & Head of Development | Sell | 3,611 | $54,237 |
| 2026-01-30 | Contineum Therapeutics, Inc. (CTNM) | CMO & Head of Development | Buy | 3,611 | $16,250 |
| 2026-01-30 | Contineum Therapeutics, Inc. (CTNM) | CMO & Head of Development | Sell | 2,800 | $39,452 |
| 2026-01-30 | Contineum Therapeutics, Inc. (CTNM) | CMO & Head of Development | Sell | 811 | $11,743 |
| 2025-12-30 | Contineum Therapeutics, Inc. (CTNM) | CMO & Head of Development | Buy | 3,611 | $16,250 |
| 2025-12-30 | Contineum Therapeutics, Inc. (CTNM) | CMO & Head of Development | Sell | 3,611 | $43,549 |
Source: SEC Form 4 filings · as of 2026-07-01